[1]Skrzynska KJ, Zachurzok A, Gawlik AM. Metabolic and hormonal profile of adolescent girls with polycystic ovary syndrome with concomitant autoimmune thyroiditis[J]. Front Endocrinol, 2021, 12: 708910. doi: 10.3389/fendo.2021.708910. [2]Joksimovic Jovic J, Sretenovic J, Jovic N, et al. Cardiovascular properties of the androgen-induced PCOS model in rats: the role of oxidative stress[J]. Oxid Med Cell Longev, 2021, 2021: 8862878. doi: 10.1155/2021/8862878. [3]刘刚, 郭山岭, 胡永寸,等. 沉默VCAM-1基因降低ox-LDL诱导的HUVECs氧化损伤和凋亡[J].基础医学与临床,2019, 39: 1423-1426. [4]Shukla P, Mukherjee S. Mitochondrial dysfunction: an emerging link in the pathophysiology of polycystic ovary syndrome[J]. Mitochondrion, 2020, 52: 24-39. [5]Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols[J]. Biomed Pharmacother, 2020, 129: 110452. doi: 10.1016/j.biopha.2020.110452. [6]Gong Y, Luo S, Fan P, et al. Growth hormone alleviates oxidative stress and improves oocyte quality in Chinese women with polycystic ovary syndrome: a randomized controlled trial[J]. Sci Rep, 2020, 10: 18769. doi: 10.1038/s41598-020-75107-4. [7]Garcia-Sanchez A, Miranda-Diaz AG, Cardona-Munoz EG. The role of oxidative stress in physiopathology and pharmacological treatment with pro-and antioxidant properties in chronic diseases[J]. Oxid Med Cell Longev, 2020, 2020: 2082145. doi: 10.1155/2020/2082145. [8]Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS[J]. Arch Physiol Biochem, 2020, 126: 183-186. [9]Jamilian M, Mansury S, Bahmani F, et al. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome[J]. J Ovarian Res, 2018, 11: 80. doi: 10.1186/s13048-018-0457-1. [10]Artimani T, Karimi J, Mehdizadeh M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS)[J]. Gynecol Endocrinol, 2018, 34: 148-152. [11]Mizgier M, Jarzabek-Bielecka G, Wendland N, et al. Relation between inflammation, oxidative stress, and macronutrient intakes in normal and excessive body weight adolescent girls with clinical features of polycystic ovary syndrome[J]. Nutrients, 2021, 13:896. doi: 10.3390/nu13030896. [12]Karamali M, Eghbalpour S, Rajabi S, et al. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial[J]. Arch Iran Med, 2018, 21: 1-7. [13]Liu Y, Liu H, Li Z, et al. The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment[J]. Front Immunol, 2021, 12: 685724. doi: 10.3389/fimmu.2021.685724. [14]Liu Q, Xie YJ, Qu LH, et al. Dyslipidemia involvement in the development of polycystic ovary syndrome[J]. Taiwan J Obstet Gynecol, 2019, 58: 447-453. [15]Nakayama A, Morita H, Kawahara T, et al. Association between testosterone and lipid profiles under statin therapy and its clinical impact on the cardiovascular event risk[J]. Heart Vessels, 2021. 36:1794-1803. [16]Gonzalez F, Considine RV, Abdelhadi OA, et al. Oxidative stress in response to saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2019, 104: 5360-5371. [17]Wang D, Wang T, Wang R, et al. Suppression of p66Shc prevents hyperandrogenism-induced ovarian oxidative stress and fibrosis[J]. J Transl Med, 2020, 18: 84. doi: 10.1186/s12967-020-02249-4. [18]Forstermann U. Nitric oxide and oxidative stress in vascular disease[J]. Pflugers Arch, 2010, 459: 923-939. [19]Adoga JO, Channa ML, Nadar A. Kolaviron attenuates cardiovascular injury in fructose-streptozotocin induced type-2 diabetic male rats by reducing oxidative stress, inflammation, and improving cardiovascular risk markers[J]. Biomed Pharmacother, 2021, 144: 112323. doi: 10.1016/j.biopha.2021.112323. [20]Liao Y, Zhu E, Zhou W. Ox-LDL aggravates the oxidative stress and inflammatory responses of THP-1 macrophages by reducing the inhibition effect of miR-491-5p on MMP-9[J]. Front Cardiovasc Med, 2021, 8: 697236. doi: 10.3389/fcvm.2021.697236. [21]Geng H, Wang A, Rong G, et al. The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway[J]. Mol Cell Biochem, 2010, 342: 201-206. [22]王美惠, 毕徐堃, 傅国胜. 瑞舒伐他汀减轻脂多糖诱导的人晚期内皮祖细胞损伤[J].基础医学与临床,2019, 39: 769-775. [23]Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species[J]. Hypertension, 2001, 37: 1450-1457. [24]Izadi A, Ebrahimi S, Shirazi S, et al. Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2019, 104: 319-327. [25]Rahmani E, Samimi M, Ebrahimi FA, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome[J]. Mol Cell Endocrinol, 2017, 439: 247-255. |